UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 15, 2023 4:30 P.M.

Form:	S-3
CIK: 0001693011 Company Name: Inozyme Pharma, Inc. File Number: 333-275364